Search

everythinglearnresearchcommunity

for

Search:↓

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Most adult chronic hair pullers are women who started in their early teens, often have other mental health issues, and may pull hair due to underlying psychiatric conditions.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Using the eye pressure medication latanoprost can cause excessive hair growth and darker eyelashes on the treated eye.

Targeted cancer therapies often cause serious skin problems that need careful management.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Latanoprost 0.1% may effectively treat hair loss.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Smad-4 and Smad-7 are key in hair follicle development, with other Smads being less important.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

CLE40 and CRN/CLV2 pathways have opposite effects on root growth in Arabidopsis.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Facial hair restoration is generally successful and satisfying for patients when done with quality techniques and realistic expectations.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Radiofrequency and scalpel incisions have similar clinical outcomes for upper eyelid surgery.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.